UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 523

Sortiert nach

Reservoir zonation, rock typing and compartmentalization of the Tortonian-Serravallian sequence, Temsah Gas Field, offshore Nile Delta, Egypt

Marine and petroleum geology, 2018-04, Vol.92, p.609-631

2018

Volltextzugriff (PDF)

Integration of seismic interpretation and well logging analysis of Abu Roash D Member, Gindi Basin, Egypt: Implication for detecting and evaluating fractured carbonate reservoirs

Journal of African earth sciences (1994), 2017-11, Vol.135, p.1-13

2017

Volltextzugriff (PDF)

Healing potential of Rosmarinus officinalis L. on full-thickness excision cutaneous wounds in alloxan-induced-diabetic BALB/c mice

Journal of ethnopharmacology, 2010-09, Vol.131 (2), p.443-450

Abu-Al-Basal, Mariam A.

2010

Volltextzugriff (PDF)

Seismic and well logging interpretation for evaluation of the lower Bahariya reservoir, southwest Qarun (SWQ) Field, Gindi Basin, Egypt

Marine geophysical researches, 2017-09, Vol.38 (3), p.271-290

2017

Volltextzugriff (PDF)

Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice

The Egyptian heart journal, 2023-08, Vol.75 (1), p.73-73, Article 73

2023

Volltextzugriff (PDF)

OC07.07: Exome sequencing for structurally normal fetuses: yields and dilemmas

Ultrasound in obstetrics & gynecology, 2022-09, Vol.60 (S1), p.22-23

2022

Volltextzugriff (PDF)

Synthesis, Characterization, and Handling of EuII-Containing Complexes for Molecular Imaging Applications

Frontiers in chemistry, 2018-03, Vol.6, p.65-65

2018

Volltextzugriff (PDF)

Influence of Nigella sativa fixed oil on some blood parameters and histopathology of skin in staphylococcal-infected BALB/c mice

Pakistan journal of biological sciences, 2011-12, Vol.14 (23), p.1038-1046

Abu-Al-Basal, Mariam A

2011

Volltextzugriff (PDF)

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

The Lancet (British edition), 2012-04, Vol.379 (9825), p.1489-1497

2012

Volltextzugriff (PDF)

Fluorinated Eu II -based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging

Chemical science (Cambridge), 2017-12, Vol.8 (12), p.8345-8350

2017

Volltextzugriff (PDF)

Genetic diagnosis of basal ganglia disease in childhood

Developmental medicine and child neurology, 2022-06, Vol.64 (6), p.743-752

2022

Volltextzugriff (PDF)

The Role of Coordination Environment and pH in Tuning the Oxidation Rate of Europium(II)

Chemistry : a European journal, 2017-01, Vol.23 (5), p.1145-1150

2017

Volltextzugriff (PDF)

Evolutionary ecology of beta‐lactam gene clusters in animals

Molecular ecology, 2017-06, Vol.26 (12), p.3217-3229

2017

Volltextzugriff (PDF)

Oxidation-Responsive, EuII/III-Based, Multimodal Contrast Agent for Magnetic Resonance and Photoacoustic Imaging

ACS omega, 2017-03, Vol.2 (3), p.800-805

2017

Volltextzugriff (PDF)

Synthesis, Characterization, and Handling of Eu II -Containing Complexes for Molecular Imaging Applications

Frontiers in chemistry, 2018-03, Vol.6, p.65

2018

Volltextzugriff (PDF)

Screening of ligands for redox-active europium using magnetic resonance imaging

Bioorganic & medicinal chemistry, 2018-10, Vol.26 (19), p.5274-5279

2018

Volltextzugriff (PDF)

Fluorinated EuII-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging

Chemical science (Cambridge), 2017-01, Vol.8 (12), p.8345-8350

2017

Volltextzugriff (PDF)

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1293

2013

Volltextzugriff (PDF)

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1293-1297

2013

Volltextzugriff (PDF)

Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial

The lancet oncology, 2014, Vol.15 (1), p.96-105

2014

Volltextzugriff (PDF)

Preparation of cellulose nanofibers from potato residues by ultrasonication combined with high-pressure homogenization

Food chemistry, 2023-07, Vol.413, p.135675-135675, Article 135675

2023

Volltextzugriff (PDF)

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin

Diabetes care, 2021-12, Vol.44 (12), p.2729-2737

2021

Volltextzugriff (PDF)

Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders

Brain communications, 2020-01, Vol.2 (2), p.fcaa178

2020

Volltextzugriff (PDF)

Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial

Diabetes, obesity & metabolism, 2015-10, Vol.17 (10), p.936-948

2015

Volltextzugriff (PDF)

The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, U.K

British journal of dermatology (1951), 2018-10, Vol.179 (4), p.824-828

2018

Volltextzugriff (PDF)

1 – 25 von 523

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(421)
Mit Volltextzugriff
(480)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Reservoir zonation, rock typing and compartmentalization of the Tortonian-Serravallian sequence, Temsah Gas Field, offshore Nile Delta, Egypt

Integration of seismic interpretation and well logging analysis of Abu Roash D Member, Gindi Basin, Egypt: Implication for detecting and evaluating fractured carbonate reservoirs

Healing potential of Rosmarinus officinalis L. on full-thickness excision cutaneous wounds in alloxan-induced-diabetic BALB/c mice

Seismic and well logging interpretation for evaluation of the lower Bahariya reservoir, southwest Qarun (SWQ) Field, Gindi Basin, Egypt

Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice

OC07.07: Exome sequencing for structurally normal fetuses: yields and dilemmas

Synthesis, Characterization, and Handling of EuII-Containing Complexes for Molecular Imaging Applications

Influence of Nigella sativa fixed oil on some blood parameters and histopathology of skin in staphylococcal-infected BALB/c mice

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Fluorinated Eu II -based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging

Genetic diagnosis of basal ganglia disease in childhood

The Role of Coordination Environment and pH in Tuning the Oxidation Rate of Europium(II)

Evolutionary ecology of beta‐lactam gene clusters in animals

Oxidation-Responsive, EuII/III-Based, Multimodal Contrast Agent for Magnetic Resonance and Photoacoustic Imaging

Synthesis, Characterization, and Handling of Eu II -Containing Complexes for Molecular Imaging Applications

Screening of ligands for redox-active europium using magnetic resonance imaging

Fluorinated EuII-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial

Preparation of cellulose nanofibers from potato residues by ultrasonication combined with high-pressure homogenization

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin

Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders

Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial

The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, U.K

Suchergebnisse filtern